Summary:
The purpose of this study is to see if an investigational [new/not available on the market and not yet approved by the U.S Food and Drug Administration (FDA) tablet is bioequivalent (where the active test study drug is absorbed into the body at the same rate and amount as an already approved drug) to a currently marketed tablet, as well as to monitor the safety of the study participants.
Qualified Participants Must:
• 18 - 55 years old
•
General good health
•
Non-smokers